4.6 Article

Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients

Zhonghan Sun et al.

Summary: The study found that COVID-19 patients had altered gut microbial composition, with a decrease in commensal species and an increase in opportunistic pathogenic species. Microbiota features associated with severe illness were linked to the host's immune response. Moreover, COVID-19 patients exhibited dysfunction of the gut barrier. These findings suggest that dysbiosis of the gut microbiome and gut barrier dysfunction may play a role in the pathophysiology of COVID-19.

BMC MEDICINE (2022)

Article Pediatrics

COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group

Dilek Yilmaz Ciftdogan et al.

Summary: This study retrospectively analyzed the clinical and laboratory features of MIS-C patients with or without overlap with Kawasaki disease (KD). The findings showed that almost half of the MIS-C patients had clinical features that overlapped with KD, especially incomplete KD. Patients with overlap with KD had lower lymphocyte and platelet counts, and higher levels of ferritin and procalcitonin.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Article Gastroenterology & Hepatology

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

Qin Liu et al.

Summary: This study investigated the link between gut microbiome composition and post-acute COVID-19 syndrome. The results showed that the gut microbiome of patients with long-term complications of COVID-19 differed significantly from that of non-COVID-19 controls and patients without post-acute COVID-19 syndrome.
Review Immunology

SARS-CoV-2 infections in children: Understanding diverse outcomes

Petter Brodin

Summary: SARS-CoV-2 infections in children usually result in mild or asymptomatic infections, and the reasons behind this are not fully understood. Possible explanations include more efficient local tissue responses, better thymic function, and crossreactive immunity. Post-infectious hyperinflammatory syndromes are rare in children and young people, but very rarely seen in adults. This article offers an additional explanation to mild infections, viral dynamics, and the higher incidence of rare multisystem inflammatory syndromes in children and young people from a life history and energy allocation perspective.

IMMUNITY (2022)

Review Infectious Diseases

Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review

Tik Fung Dave Liu et al.

Summary: Studies have shown significant changes in the composition of gut and airway microbiota in COVID-19 infection, with most indicating a decrease in microbial diversity and development of intestinal dysbiosis in patients. More carefully designed studies are needed to provide conclusive evidence on the role of these microbiota in COVID-19.

INFECTION (2022)

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

Review Critical Care Medicine

Multisystem Inflammatory Syndrome in Children: Host Immunologic Responses

Monty B. Mazer et al.

PEDIATRIC CRITICAL CARE MEDICINE (2022)

Letter Gastroenterology & Hepatology

Six-month follow-up of gut microbiota richness in patients with COVID-19

Yanfei Chen et al.

Article Medicine, General & Internal

Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative

Blake Martin et al.

Summary: This study examined characteristics, outcomes, and risk factors of SARS-CoV-2 in US children. Differences in demographics, comorbidities, and initial vital signs/lab values were observed among severity subgroups. Early identification of high-risk children could improve outcomes.

JAMA NETWORK OPEN (2022)

Article Biology

Long COVID in Children and Adolescents

Valentina Fainardi et al.

Summary: Long-term COVID-19 in children may be a relevant clinical problem, with most cases having a good prognosis but some children experiencing long-term symptoms that significantly impact their daily life. The lack of research on long COVID in children, including a control group of uninfected children, prevents firm conclusions from being drawn. The cause of neuropsychiatric symptoms in children with long COVID is still unclear, but psychological support can play a fundamental role in managing the pandemic in children. More knowledge is needed to standardize the definition of the syndrome and improve its management and treatment.

LIFE-BASEL (2022)

Article Respiratory System

Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

Ismail M. Osmanov et al.

Summary: This study aimed to assess the long-term outcomes in children previously hospitalized with COVID-19 and found that a quarter of children experienced persistent symptoms months after hospitalization. Older age and allergic diseases were associated with a higher risk of persistent symptoms at follow-up.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Microbiology

Long-term outcomes of pediatric infections: from traditional infectious diseases to long covid

Danilo Buonsenso et al.

Summary: The article analyzes the evidence on pediatric long covid and lessons learnt from a pediatric post-covid unit in Rome, Italy. It also examines the long-term effects of other infectious diseases. Understanding the potential long-term consequences of this novel infection is crucial, as long-term effects of post-infectious diseases are not new phenomena.

FUTURE MICROBIOLOGY (2022)

Article Pediatrics

Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study)

Dilek Yilmaz Ciftdogan et al.

Summary: This study describes the clinical features, laboratory characteristics, and outcomes of children diagnosed with MIS-C in 25 different hospitals in Turkey. The study found that MIS-C has a broad clinical spectrum and most patients were previously healthy. Prompt diagnosis and treatment are essential for the management of MIS-C.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2022)

Article Immunology

Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus

Flavio De Maio et al.

Summary: The study investigated fecal microbiota composition in infants with RSV and non-RSV bronchiolitis, finding significant differences in clinical characteristics between the two groups, but no direct association between microbiota composition and severity of bronchiolitis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Review Pediatrics

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections

Petra Zimmermann et al.

Summary: The severity of COVID-19 differs between children and adults, with factors that put adults at higher risk and factors that protect children being the main reasons for this difference.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.
Review Microbiology

Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update

Carolina Ferreira et al.

Summary: The composition of gut microbiota may play a role in the severity of COVID-19 infection, as it is related to immune system response, gastrointestinal symptoms, and the virus receptor ACE2. Patients with pre-existing chronic diseases are more likely to have dysbiosis in gut microbiota, and those with severe outcomes often exhibit hyperresponsiveness of the immune system and a cytokine storm, which may be associated with impaired microbiota phenotype.

MICROORGANISMS (2021)

Article Biochemistry & Molecular Biology

Reporting guidelines for human microbiome research: the STORMS checklist

Chloe Mirzayi et al.

Summary: The STORMS tool is a reporting guideline for human microbiome studies, consisting of a 17-item checklist to help researchers report study results concisely and completely, facilitating manuscript preparation, peer review, and reader comprehension.

NATURE MEDICINE (2021)

Review Rheumatology

Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

Chetan Sharma et al.

Summary: Children and adolescents infected with SARS-CoV-2 often exhibit mild symptoms, but may also develop a pediatric systemic vasculitis called MIS-C. This condition shares features with myocarditis and Kawasaki disease. Research indicates that MIS-C is a result of an exaggerated immune response triggered by prior exposure to SARS-CoV-2.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

Leora R. Feldstein et al.

Summary: Comparing the clinical characteristics and outcomes of patients with MIS-C and COVID-19 can help distinguish between the two conditions and improve health outcomes. Patterns of clinical presentation and organ system involvement were identified in this case series, providing valuable information for differentiation of MIS-C and COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Pediatrics

COVID-19 in children and the importance of COVID-19 vaccination

Feng-Xia Xue et al.

WORLD JOURNAL OF PEDIATRICS (2021)

Review Immunology

Viral Infections, the Microbiome, and Probiotics

Ashton Harper et al.

Summary: Viral infections continue to pose significant global morbidity and mortality, with factors such as climate change, increased mobility of people and goods, and disruptions in the gastrointestinal microbiome all playing a role. Understanding the complex relationship between the microbiome, viral immunity, and host physiology is crucial for developing effective prevention and treatment strategies for viral diseases.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota

Sijia Li et al.

Summary: The study shows significant alterations of gut microbiota in patients with COVID-19, which are related to disease severity. Analysis of gut microbiome can distinguish COVID-19 patients from healthy individuals, providing new insights for early diagnosis.

FRONTIERS IN MICROBIOLOGY (2021)

Review Pharmacology & Pharmacy

Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders

Tatiani Uceli Maioli et al.

Summary: Research has shown a direct link between the composition of the gut microbiota and the pathogenesis of obesity and diabetes. An obesity-inducing diet can lead to increased gut permeability and microbial dysbiosis, contributing to chronic inflammation and insulin resistance. Modulating the gut microbiota may be a potential treatment approach for these conditions.

FRONTIERS IN PHARMACOLOGY (2021)

Article Immunology

Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children

Anjali Ramaswamy et al.

Summary: Through various analyses, specific biological features were identified in MIS-C patients, including myeloid dysfunction, elevated cytotoxicity gene expression in NK and CD8(+) T cells, and autoimmune characteristics, which could potentially improve the diagnosis and prediction of disease severity in MIS-C.

IMMUNITY (2021)

Review Medicine, General & Internal

Microbiota and Its Impact on the Immune System in COVID-19-A Narrative Review

Marzena Jabczyk et al.

Summary: The intestinal microbiota may play a crucial role in combating COVID-19 by affecting the host immune system through the gut-lung axis and gut-brain axis. The presence of ACE2 receptor in SARS-CoV-2 and its connection to gut microbiota suggests a relationship between COVID-19 and the gut microbiome, with the severity of the disease potentially linked to various comorbidities.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Microbiology

Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus

Alok K. Paul et al.

Summary: Rheumatoid arthritis is a chronic autoimmune disorder with various potential causes, and probiotics such as L. casei or L. acidophilus may have a beneficial role in its management.

MICROORGANISMS (2021)

Article Microbiology

Amplicon Sequence Variants Artificially Split Bacterial Genomes into Separate Clusters

Patrick D. Schloss

Summary: ASVs have become popular for analyzing microbial communities as they do not cluster sequences based on distance thresholds, but using overly narrow thresholds may increase the risk of splitting a single genome. The study found that as the number of 16S rRNA gene copies in a genome increased, the number of ASVs also increased, with a distance threshold of 5.25% required to cluster ASVs from the same genome into a single OTU. This research highlights the risk of artificially splitting bacterial genomes when using ASVs for 16S rRNA gene sequence analysis.

MSPHERE (2021)

Review Immunology

Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention

Geraldine Blanchard-Rohner et al.

Summary: Children exhibit unique characteristics in the context of the COVID-19 pandemic, showing lower medical impact compared to adults but developing a severe and unique complication known as multisystem inflammatory syndrome. Their contribution to the transmission of SARS-CoV-2 appears lower than that of adults, which must be considered when vaccinating them.

VACCINES (2021)

Review Microbiology

Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics

Yuan-Pin Hung et al.

Summary: SARS-CoV-2 primarily infects the lungs through respiratory transmission but can also cause gastrointestinal inflammation, potentially affecting the severity of COVID-19. Probiotics play a crucial role in maintaining gut microbiota balance and may have potential preventive or therapeutic effects for COVID-19 patients.

MICROORGANISMS (2021)

Review Microbiology

Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases

Yi-Wen Tsai et al.

Summary: Autoimmunity is a complex process that affects multiple organs and tissues, contributing to a decline in functionality. The pandemic of autoimmune diseases globally increases the prevalence and incidence of diseases like type 1 diabetes, multiple sclerosis, and rheumatoid arthritis. The role of gut microbiota in the development of autoimmune diseases is significant, but the interrelationships with the immune system during disease progression are still not well understood.

MICROORGANISMS (2021)

Article Medicine, General & Internal

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

Lyudmyla Kompaniyets et al.

Summary: This study investigated the risk of severe COVID-19 illness among children with underlying medical conditions and medical complexity. It found that children with type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity had a higher risk of severe COVID-19 illness, highlighting the importance of close observation and cautious clinical management for these children.

JAMA NETWORK OPEN (2021)

Article Nutrition & Dietetics

Impact of COVID-19 on the Intestinal Microbiome

Carla Venegas-Borsellino et al.

Summary: This review explores the gastrointestinal changes induced by SARS-CoV-2, the influence of gut microbial homeostasis on these changes, and the relationship with the lung-gut axis and cytokine release syndrome induction in severe COVID-19 patients. Understanding how gut dysbiosis may impact viral transmission and disease progression in COVID-19 could potentially inform accessible therapies, such as diet modulation, to mitigate the devastating consequences of COVID-19.

CURRENT NUTRITION REPORTS (2021)

Review Medicine, Research & Experimental

Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature

Shuming Jiang et al.

Summary: Eggerthella lenta, a normal human microflora, has been shown to potentially become a significant pathogen causing life-threatening infections. However, further clinical data are needed to improve understanding of its pathogenic mechanism and treatment options.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2021)

Article Gastroenterology & Hepatology

The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort

Rachel C. Newsome et al.

Summary: The study found significant differences in the fecal microbial composition between COVID-19 patients and controls, as well as between actively infected patients and recovered patients. Certain genera like Campylobacter and Klebsiella were enriched in COVID-19 patients with gastrointestinal symptoms. Additionally, a substantial proportion of COVID-19 patients tested positive for fecal SARS-CoV-2 RNA. Further research is needed to explore the functional impact of SARS-CoV-2 on gastrointestinal health.

GUT MICROBES (2021)

Article Biochemistry & Molecular Biology

Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19

Rong Xu et al.

Summary: Children infected with SARS-CoV-2 may experience significant alterations in their upper respiratory and gut microbiomes, characterized by dysbiosis and sustained changes lasting for a considerable period. This could indicate potential long-term complications post-recovery from COVID-19.

JOURNAL OF GENETICS AND GENOMICS (2021)

Article Physiology

Silent hypoxia in COVID-19: a gut microbiota connection

B. Akshita Gopal et al.

Summary: SARS-CoV-2 infection can lead to silent hypoxia, where individuals infected with the virus may not show respiratory distress symptoms despite having low oxygen levels in their blood. Prolonged undetected hypoxia can be dangerous and even fatal. The exact mechanisms behind silent hypoxia caused by SARS-CoV-2 are still not fully understood.

CURRENT OPINION IN PHYSIOLOGY (2021)

Article Medicine, Research & Experimental

Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier

Lael M. Yonker et al.

Summary: In children with MIS-C, prolonged presence of SARS-CoV-2 in the GI tract led to the release of zonulin, a biomarker of intestinal permeability, and subsequent trafficking of SARS-CoV-2 antigens into the bloodstream, resulting in hyperinflammation. Treatment with larazotide, a zonulin antagonist, reduced plasma SARS-CoV-2 spike antigen levels and inflammatory markers in a patient with MIS-C, leading to clinical improvement beyond current available treatments. These mechanistic insights provide potential targets for diagnosing, treating, and preventing MIS-C in children.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Rheumatology

The oral and gut microbiome in rheumatoid arthritis patients: a systematic review

Xiu-Jie Chu et al.

Summary: Research has found some differences in the oral and gut microbiome of rheumatoid arthritis (RA) patients compared to healthy controls, including decreases and increases in specific bacteria. The alpha-diversity of the microbiome in the oral cavity may increase or remain unchanged, while it is more commonly decreased or unchanged in the gut microbiome of RA patients. More research is needed to explore the deep relationship between RA and the microbiome.

RHEUMATOLOGY (2021)

Article Medicine, Research & Experimental

HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children

Rebecca A. Porritt et al.

Summary: Our study found a significant expansion of TCR beta variable gene 11-2 (TRBV11-2) in MIS-C patients, with extensive junctional diversity observed in the expanded TRBV11-2 clones. This expansion was correlated with the severity of MIS-C and serum cytokine levels, suggesting a novel mechanism of T cell expansion independent of CDR3. Additionally, in silico modeling indicated a potential interaction between the V beta chain encoded by TRBV11-2 and the superantigen-like motif of SARS-CoV-2 spike glycoprotein, possibly mediating T cell expansion and activation in MIS-C patients.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Gastroenterology & Hepatology

Integrated gut virome and bacteriome dynamics in COVID-19 patients

Jiabao Cao et al.

Summary: Research shows that COVID-19 patients have distinct gut virome and bacteriome compared to healthy individuals, with a bacterial dysbiosis signature. Differences in bacterial/viral compositions were observed in patients of different severities, with severe cases having more opportunistic pathogens and fewer butyrate-producing bacteria.

GUT MICROBES (2021)

Article Critical Care Medicine

Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients

Robert P. Dickson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Immunology

The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks

Raphael Enaud et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Gastroenterology & Hepatology

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Tao Zuo et al.

GASTROENTEROLOGY (2020)

Article Food Science & Technology

Potential contribution of beneficial microbes to face the COVID-19 pandemic

Adriane E. C. Antunes et al.

FOOD RESEARCH INTERNATIONAL (2020)

Article Biochemistry & Molecular Biology

Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer

Lidia Sanchez-Alcoholado et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease

Jie Chen et al.

SCIENTIFIC REPORTS (2020)

Review Infectious Diseases

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Li Jiang et al.

LANCET INFECTIOUS DISEASES (2020)

Article Medicine, Research & Experimental

Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension

Nosheen Mushtaq et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)

Letter Biotechnology & Applied Microbiology

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Evan Bolyen et al.

NATURE BIOTECHNOLOGY (2019)

Review Biochemistry & Molecular Biology

The Gut Microbiota in the First Decade of Life

Muriel Derrien et al.

TRENDS IN MICROBIOLOGY (2019)

Review Rheumatology

The microbiome in systemic autoimmune disease: mechanistic insights from recent studies

Carina Dehner et al.

CURRENT OPINION IN RHEUMATOLOGY (2019)

Article Multidisciplinary Sciences

Virus-virus interactions impact the population dynamics of influenza and the common cold

Sema Nickbakhsh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease

Kinga Kowalska-Duplaga et al.

SCIENTIFIC REPORTS (2019)

Review Medicine, General & Internal

The role of the gut microbiome in systemic inflammatory disease

Jose C. Clemente et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

The role of the gut microbiome in systemic inflammatory disease

Jose C. Clemente et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Endocrinology & Metabolism

Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling

T. Pallister et al.

INTERNATIONAL JOURNAL OF OBESITY (2017)

Article Biochemical Research Methods

DADA2: High-resolution sample inference from Illumina amplicon data

Benjamin J. Callahan et al.

NATURE METHODS (2016)

Review Nutrition & Dietetics

The Intestinal Microbiota in Metabolic Disease

Anni Woting et al.

NUTRIENTS (2016)

Article Genetics & Heredity

An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

Jun Chen et al.

GENOME MEDICINE (2016)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Multidisciplinary Sciences

Richness of human gut microbiome correlates with metabolic markers

Emmanuelle Le Chatelier et al.

NATURE (2013)

Article Multidisciplinary Sciences

Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance

Xiuying Zhang et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

Tatsuo Hashimoto et al.

NATURE (2012)

Article Multidisciplinary Sciences

A metagenome-wide association study of gut microbiota in type 2 diabetes

Junjie Qin et al.

NATURE (2012)

Review Gastroenterology & Hepatology

The role of gut microbiota in immune homeostasis and autoimmunity

Hsin-Jung Wu et al.

GUT MICROBES (2012)

Article Biotechnology & Applied Microbiology

Metagenomic biomarker discovery and explanation

Nicola Segata et al.

GENOME BIOLOGY (2011)

Article Multidisciplinary Sciences

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)